N Verses Capital, LLC Alkermes Plc. Transaction History
N Verses Capital, LLC
- $41.7 Billion
- Q1 2024
A detailed history of N Verses Capital, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,100 shares of ALKS stock, worth $82,181. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,100Holding current value
$82,181% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$773 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$534 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$239 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$221 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.35B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...